HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgM and IgG cystatin capture enzyme linked immunosorbent assays: a tool for serodiagnosis and assessment of cure of acute fascioliasis after triclabendazole (TCZ; Fasinex) therapy.

Abstract
This study included 71 individuals: 25 patients with confirmed acute fascioliasis, 9 patients with suspected fascioliasis, 27 patients with parasitic infections other than fascioliasis and 10 normal controls. Patients with fascioliasis were treated with TCZ as a single dose and followed up 1 and 4 months after therapy. The results showed that both IgM and IgG cystatin capture ELISAs had very high sensitivity and specificity of 100%. They were also able to diagnose early fascioliasis even before indirect haemagglutination test (IHAT) became positive. Within 4 months after treatment, only 20 patients (80%) with fascioliasis were cured as evidenced clinically, by normal eosinophil count and negative IHAT. After the first month of treatment, IgM and IgG cystatin capture ELISAs became negative in 16.6% and 83.3% of the cured cases respectively, reaching 95% for both assays after 4 months. They remained positive in 5 cases (20%) not responding to treatment.
AuthorsG M Tawfeek, D A Hussein
JournalJournal of the Egyptian Society of Parasitology (J Egypt Soc Parasitol) Vol. 30 Issue 3 Pg. 679-97 (Dec 2000) ISSN: 1110-0583 [Print] Egypt
PMID11198366 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anthelmintics
  • Benzimidazoles
  • Cystatins
  • Immunoglobulin G
  • Immunoglobulin M
  • Triclabendazole
Topics
  • Acute Disease
  • Adult
  • Anthelmintics (therapeutic use)
  • Benzimidazoles (therapeutic use)
  • Cystatins (analysis, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Fascioliasis (diagnosis, drug therapy)
  • Female
  • Humans
  • Immunoglobulin G (analysis)
  • Immunoglobulin M (analysis)
  • Male
  • Middle Aged
  • Triclabendazole

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: